Philikos B.V.

1 trials 1 recruiting Commercial sponsor

Filter these 1 trials by condition, phase, country and more.

1 Registered trials

1 Recruiting

0 Completed trials

1 Countries active

1 Unique IMPs

N/A Results reported

Phase I/II

Top IMPs

1 total

T-Guard in dcSSc Recruiting

2024-517283-28-00 Phase I/II 1 country DAFSOLIMAB SETARITOX, GRISNILIMAB SETARITOX

Showing 1–1 of 1 trials